Structured Data Collection of Patients Undergoing Liver Transplantation and Evaluated for Bone Mineral Metabolism
Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Feb 19, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how liver transplantation affects bone health, specifically looking at conditions like osteoporosis, which is when bones become weak and brittle. The researchers want to collect information from patients who are having their first check-up or a follow-up visit related to their bone health after receiving a liver transplant. This will help them understand how bone mineral metabolism, or the process of maintaining healthy bones, is influenced by liver transplant surgery.
If you are over 18 years old and have undergone a liver transplant for any reason, you may be eligible to participate in this study. During the trial, participants will undergo tests to measure bone density and other aspects of bone health. There are no specific exclusions, so most liver transplant patients can join. By participating, you’ll help contribute to important research that could improve care for future patients facing similar health challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>18 years
- • Patients undergoing liver transplantation for any cause.
- • Performance of bone densitometry
- • Performance of examinations pertaining to mineral metabolism
- • Obtaining informed consent
- Exclusion Criteria:
- • none
About Irccs Azienda Ospedaliero Universitaria Di Bologna
IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Trial Officials
Uberto Pagotto, MD
Principal Investigator
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported